AstraZeneca’s COVID-19 vaccine defies data controversy with 76% effectiveness in phase 3
TrustVaccines
via FiercePharma: Vaccines https://ift.tt/2zKtXvv
March 25, 2021 at 08:41AM
AstraZeneca’s COVID-19 vaccine defies data controversy with 76% effectiveness in phase 3
Welcome to vaccine education 